Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation.
about
hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineHematopoietic stem cell expansion and generation: the ways to make a breakthroughLost in translation: pluripotent stem cell-derived hematopoiesisProgress and obstacles towards generating hematopoietic stem cells from pluripotent stem cellsHematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells.Gene therapy on the moveInduced pluripotent stem cells in hematology: current and future applicationsThe RUNX1 +24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cellsTranslation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicineModeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome EngineeringSurvival regulation of leukemia stem cellsCongenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling.Modified lentiviral LTRs allow Flp recombinase-mediated cassette exchange and in vivo tracing of "factor-free" induced pluripotent stem cells.Engineering the haemogenic niche mitigates endogenous inhibitory signals and controls pluripotent stem cell-derived blood emergence.Cell replacement therapies: is it time to reprogram?Generation and homing of iPSC-derived hematopoietic cells in vivoInduced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.Generation of X-CGD cells for vector evaluation from healthy donor CD34(+) HSCs by shRNA-mediated knock down of gp91(phox).De novo generation of HSCs from somatic and pluripotent stem cell sources.Placenta-based therapies for the treatment of epidermolysis bullosaRescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model.Development of hematopoietic stem and progenitor cells from human pluripotent stem cells.Making a Hematopoietic Stem CellConverting cell fates: generating hematopoietic stem cells de novo via transcription factor reprogrammingDonor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines.In vivo differentiation of induced pluripotent stem cells into neural stem cells by chimera formation.Multiple sclerosis: getting personal with induced pluripotent stem cells.The hematopoietic system in the context of regenerative medicine.From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.Cloning and variation of ground state intestinal stem cellsCell Therapy Strategies to Combat Immunosenescence.A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells.Role of mesenchymal stem cells in cell life and their signaling.Concise Review: Getting to the Core of Inherited Bone Marrow Failures.Cocktail of chemical compounds robustly promoting cell reprogramming protects liver against acute injuryGeneration of in vivo neural stem cells using partially reprogrammed cells defective in in vitro differentiation potential.Generation of hematopoietic stem cells from human embryonic stem cells using a defined, stepwise, serum-free, and serum replacement-free monolayer culture method.Ex vivo production of platelets from stem cells.Skeletal muscle tissue engineering: strategies for volumetric constructs.Cell therapies for treatment of human immunodeficiency virus infection.
P2860
Q26751506-21F37D33-C665-4F02-A484-9ACFEC8779DCQ26771763-0DDA311A-FCF1-481C-8AEC-7D3F736F42E5Q26801840-FB90C901-73A3-4C6E-AB2A-6F54D73001DAQ26824479-E169D1AD-FD2A-41E2-8B67-5AF3A1CDA1AAQ26851475-993CA9CE-188F-4E4D-BFC7-B5D768450160Q27007012-926E1A1D-BCB9-4121-BBD7-C1591EC64347Q27016090-C7089203-0077-4FF6-AEAF-196E4241BFE6Q27329605-14ABBC0D-EDA0-4BAC-9161-7796616FDA41Q28076397-0199FF16-BFDA-488C-B941-7114C88ABBCFQ28083303-E7374062-0CC6-452B-A4F7-7AC124F0BFF5Q28271278-0017B7A9-F536-4413-BAFC-329E9BDF8131Q33409483-6D5D9DFA-D863-4123-A21B-8736627A584DQ33587018-313DFF86-6AB9-49F1-AB92-5BA39A2C7AF9Q33815740-C268C0E9-D395-4C25-8984-CDC4657C461DQ34267315-72617EED-6A43-4219-AB31-C97029513F6DQ34354372-58589C4D-21F5-4453-B8FC-07393D3184CDQ35037783-CD65449A-8C52-4533-95F5-5E55A9CF5BDCQ35184193-DBDC26FC-3224-423E-8C2B-F7F4CBC771B4Q35533599-9ED364A1-C027-43BD-BD9C-50AD50E1B83FQ35582332-9F747EEE-1A35-4C1A-9994-1F2B6C9FA8DDQ35637089-9899B218-EBD0-4599-873B-1701DCF12E67Q35676075-FBBEDCAF-CD38-4A31-93E8-BC454EC3FE56Q35829658-44F79825-778A-489E-AF5A-DC022A080167Q35889520-34763E7B-58F9-4DB4-8317-67557032F56DQ35944308-4FF93A92-A34F-4F68-A2BC-DE85BCCC900FQ36264901-AF5558E9-4F8C-456F-A77B-02E65D3C65C9Q36293848-A910D3C0-71CE-4A0E-85A0-D9BA89F4F49AQ36627127-94BAAE91-FC77-420D-9C84-D2E1E54587DAQ36756725-CB5B6C3B-CADB-4294-8109-6015D41BD706Q36860891-0F3482C9-1C29-48C3-8A1A-3FED20710882Q36934797-FF834C31-7A0B-4757-A427-7D5BBD216767Q37299126-FF301CB5-D544-4EBC-9EC7-1D927D21732EQ37589437-991D1776-DFB0-4286-8BEF-3CC3BDD8DD99Q37633372-41889FF9-7976-43D8-83C9-4D43EFB1C13CQ37712423-2EA5CFAA-986C-44D5-B0C9-5A35BFD4ED6BQ37725454-ED2903F2-3058-45F6-A904-0C1919B452DCQ37740413-ADB175E8-3B11-4DCC-AA12-5C846EABB817Q38187494-3DE6EDC9-B42B-4430-B7B2-ACF1A90B33A0Q38258077-84FCBBE0-29E4-4EF2-9330-C76332338EA0Q38366376-6EF8BD2E-C28C-42D2-9CBC-4FB4B364C538
P2860
Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Generation of engraftable hema ...... by way of teratoma formation.
@ast
Generation of engraftable hema ...... by way of teratoma formation.
@en
Generation of engraftable hema ...... by way of teratoma formation.
@nl
type
label
Generation of engraftable hema ...... by way of teratoma formation.
@ast
Generation of engraftable hema ...... by way of teratoma formation.
@en
Generation of engraftable hema ...... by way of teratoma formation.
@nl
prefLabel
Generation of engraftable hema ...... by way of teratoma formation.
@ast
Generation of engraftable hema ...... by way of teratoma formation.
@en
Generation of engraftable hema ...... by way of teratoma formation.
@nl
P2093
P2860
P356
P1433
P1476
Generation of engraftable hema ...... s by way of teratoma formation
@en
P2093
Hideki Masaki
Hiromitsu Nakauchi
Motohito Okabe
Satoshi Takaki
Satoshi Yamazaki
Tomoyuki Yamaguchi
P2860
P304
P356
10.1038/MT.2013.71
P577
2013-05-14T00:00:00Z